港股收評:恆生科技指數一度大跌1.8%,醫藥股全線暴跌
今日,港股繼續走弱,三大指數盤中均大幅下挫,恆生科技指數一度大跌1.8%,尾盤跌幅有所收窄。截至收盤,恆指跌0.25%報28072點,國指跌0.04%報10269點,恆生科技指數跌0.85%報7646點。

盤面上,醫藥股全線大跌,汽車股、半導體、光伏等熱門板塊下跌明顯,在線教育股與餐飲股反彈,金融股(保險、券商、銀行)、內房股多數上揚,大型科技股尾盤小幅拉昇,阿裏巴巴轉漲至1.65%,騰訊收漲0.9%。
具體來看:
醫藥股重挫。復星醫藥領跌8%,康哲藥業、同仁堂科技、康龍化成等跌超6%,阿裏健康、四環醫藥、聯邦製藥等跌超5%,麗珠醫藥、先聲藥業等跌超4%。


有分析人士指出,醫藥股暴跌主要有兩個原因:一是CDE發佈關於公開徵求《以臨牀價值爲導向的抗腫瘤藥物臨牀研發指導原則》,市場解讀成利空,導致CRO概念股全線大跌;二是醫藥板塊前期漲幅較大,獲利盤較多,近期市場整體調整,在CRO概念的大跌拖累下,導致整個板塊出現明顯波動。
航運及港口板塊跌幅居前。永豐集團控股跌超22%,潤利海事、中遠海發、廈門港務等跟跌。

汽車板塊走弱。東風集團跌超4%,比亞迪股份、恆大汽車跌超3%,廣汽集團、長城汽車、吉利汽車等跟跌。

半導體板塊普跌。先思行跌超4%,上海復旦、中芯國際、中電華大科技跌超2%。

化肥股表現強勢。中化化肥、中海石化漲超11%,中國心連心化肥漲超9%,世紀陽光漲超2%。

昨日,中國化肥價格系列指數全線上揚,尿素批發價格指數再創新峯值。花旗發表研究報告稱,考慮到全球化肥產品供應緊張及燃氣作爲原料的成本優勢擴大,預期中海石化將發佈盈喜,基於其估值及派息吸引,重申買入評級。
教育股反彈。天立教育漲近6%,睿見教育、新東方-S漲超3%,大山教育、21世紀教育、思考樂教育等跟漲。

餐飲股走強。MS CONCEPT 漲超18.18%,太平洋酒吧漲超11%,高門集團漲超8%,海底撈漲超5%。

保險股普漲。中國太保漲超3%,中國平安、新華保險、中國人壽等跟漲。

個股方面,錦欣生殖跌超10%,報17.46港元/股,總市值437.82億港元。消息面上,錦欣生殖母公司Jinxin Fertility Investment Group Ltd.計劃配售4200萬股錦欣生殖股票,配售價介乎18.22至18.72港元,較週一收市價19.54港元折讓4.2%至6.8%,涉資最多7.9億港元。

中遠海控早盤走強,股價創2009年以來新高。截至收盤,該股股價漲6%,報15.9港元/股,最新市值1958.24億港元。招商證券近日發佈研報稱,基於較高的行業景氣度,該行預計中遠海控2021年運量同比增加9.5%;由於公司自4 月開始執行新合同運價,預計全年單箱收入同比增長64%,上調全年業績爲710億元。從季度來看,Q2/Q3 或將爲盈利高點,預計即期運價在Q4 逐步回落。

南向資金今日淨賣出18.46億港元,其中,港股通(滬)淨買入6.56億港元,港股通(深)淨賣出25.03億港元。

老虎證券認爲,在國內相對低的通脹預期壓力和貨幣政策常態化約束性下,港股市場漲幅上半年雖不及海外,但積累的風險也相對較小,這樣的差距有望在下半年歐美流動性邊際收緊後,逐漸收斂。目前國內常態化、進退有序的貨幣政策,加上美聯儲QE減量前,海外流動性壓力尚不大,也包括海外通脹峯值過後,明年美國通脹問題可能因爲高基數緩解,同樣會給貨幣政策預期預留出了喘息的時間。從長期來看,這些都爲當下的港股提供了更友好的環境。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.